Kuanyshbek Alua, Yadegari Hamideh, Müller Jens, Hamedani Nasim Shahidi, Ramaraje Samhitha Urs, Oldenburg Johannes
Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Bonn.
Haematologica. 2025 Jan 9. doi: 10.3324/haematol.2023.284919.
Von Willebrand factor (VWF) plays a critical role in hemostasis, and emerging evidence suggests its involvement in inflammation. Our study aimed to investigate the interaction between circulating plasma VWF and neutrophils (polymorphonuclear cells, PMNs), elucidate the fate of VWF after binding, and explore its impact on neutrophil behavior. Neutrophils were isolated from the whole blood of healthy volunteers, and their interaction with plasma VWF was examined ex vivo. Immunofluorescence imaging revealed an enhanced binding of VWF to neutrophils following stimulation with inflammatory agents (PMA, TNFα, and IL-8) and exposure to shear forces, highlighting a previously unknown interaction. Furthermore, immunofluorescence images demonstrated increased co-localization of VWF with the early endosome marker EEA1 and the late endosome marker Rab7 over time, indicating the uptake of VWF by neutrophils subsequent to the binding. This was supported by a significant decrease in VWF antigen levels in the supernatant of cells after stimulation. Moreover, stimulated neutrophils exposed to purified plasma-derived VWF exhibited elevated expression of neutrophil surface markers CD45 and CD66b, indicative of altered neutrophil function related to cell adhesion, migration, and phagocytosis. These findings suggest that VWF binding can modulate neutrophil function, potentially influencing their role in immune responses and inflammation. In summary, our study provides novel insights into the complex interplay between VWF and neutrophils, shedding light on the multifaceted roles of VWF in inflammation. Importantly, we have identified neutrophils as potential cellular mediators involved in the clearance of VWF from circulation, introducing a novel mechanism for VWF removal.
血管性血友病因子(VWF)在止血过程中起关键作用,并且新出现的证据表明其与炎症有关。我们的研究旨在调查循环血浆VWF与中性粒细胞(多形核细胞,PMN)之间的相互作用,阐明结合后VWF的命运,并探索其对中性粒细胞行为的影响。从健康志愿者的全血中分离出中性粒细胞,并在体外检测它们与血浆VWF的相互作用。免疫荧光成像显示,在用炎性介质(PMA、TNFα和IL-8)刺激并暴露于剪切力后,VWF与中性粒细胞的结合增强,突出了一种先前未知的相互作用。此外,免疫荧光图像显示,随着时间的推移,VWF与早期内体标记物EEA1和晚期内体标记物Rab7的共定位增加,表明结合后中性粒细胞摄取了VWF。刺激后细胞上清液中VWF抗原水平显著降低支持了这一点。此外,暴露于纯化的血浆来源VWF的刺激中性粒细胞表现出中性粒细胞表面标记物CD45和CD66b的表达升高,这表明与细胞粘附、迁移和吞噬作用相关的中性粒细胞功能发生了改变。这些发现表明VWF结合可以调节中性粒细胞功能,可能影响它们在免疫反应和炎症中的作用。总之,我们的研究为VWF与中性粒细胞之间的复杂相互作用提供了新的见解,揭示了VWF在炎症中的多方面作用。重要的是,我们已将中性粒细胞确定为参与从循环中清除VWF的潜在细胞介质,引入了一种清除VWF的新机制。